Eli Lilly | Market Exclusive

Home Tags Eli Lilly

Market Morning: GM Sues Fiat, Pharma Fights for Pricing Privacy, More...

ME Staff - November 21, 2019 0

Here’s What The FDA Knock Back Means For Incyte Corporation (NASDAQ:INCY)...

- April 17, 2017 0

DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) Moves Forward With Flagship Chemotherapy Into Phase...

David Rich - February 6, 2017 0

Here’s What’s Important About Alder Biopharmaceuticals Inc (NASDAQ:ALDR)’s Latest Release

- July 26, 2016 0

Here’s What Opko Gets For Its $60 Million Transition Fee –...

- July 5, 2016 0

The Top Four Diabetes Best Sellers and One Oral Insulin Pill...

David Rich - June 22, 2016 0

Our March highlight just gained 50%: Alder Biopharmaceuticals Inc (NASDAQ:ALDR)

Roger Hannington - March 29, 2016 0

Halozyme Just First-Dosed in a Blockbuster Oncology Phase III

ME Staff - March 17, 2016 0

Alder is a Risky Allocation in a Crowded, but Rewarding Space

- February 8, 2016 0

What are the Implications of Eli Lilly’s FDA Black Box?

Roger Hannington - November 27, 2015 0

12 Page 1 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Eli Lilly

Market Morning: GM Sues Fiat, Pharma Fights for Pricing Privacy, More...

Here’s What The FDA Knock Back Means For Incyte Corporation (NASDAQ:INCY)...

DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) Moves Forward With Flagship Chemotherapy Into Phase...

Here’s What’s Important About Alder Biopharmaceuticals Inc (NASDAQ:ALDR)’s Latest Release

Here’s What Opko Gets For Its $60 Million Transition Fee –...

The Top Four Diabetes Best Sellers and One Oral Insulin Pill...

Our March highlight just gained 50%: Alder Biopharmaceuticals Inc (NASDAQ:ALDR)

Halozyme Just First-Dosed in a Blockbuster Oncology Phase III

Alder is a Risky Allocation in a Crowded, but Rewarding Space

What are the Implications of Eli Lilly’s FDA Black Box?

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY